SFHI, January 20-21, 2016
Visit Omixon at the SFHI Conference in Paris, France. Read more on the SFHI website here…
New Distributor in South Korea
Omixon announce today a new partnership with Commugene in South Korea. Through our cooperation, from one of the fastest growing markets in the world, researchers in the biotechnology industry will have easier access to Omixon’s high-performance, high-throughput and high-resolution multi-sample kit and software only products for HLA genotyping analysis by Next Generation Sequencing for use on the...
Join Omixon for our Two Workshops and Lunchtime Symposium at ASHI 2016
Lunch Symposium: NGS Accreditation for the ASHI Standards Omixon’s Lunch Symposium will focus on the ASHI accreditation process for NGS using the latest ASHI standards and feature three presentations from current Holotype HLA users in the United States. Omixon’s CEO, Tim Hague will announce major product innovations and the latest company news. Date: Thursday, 29th September, 2016...
Omixon Announce New Members of the Scientific Advisory Board
We are very pleased to announce the addition of three leading international advisors of our community to our Scientific Advisory Board: Dominique Charron MD, PhD, Malek Kamoun, MD, PhD and Matthew Anderson, MD, PhD. The Advisors, chaired by Prof. Dimitri Monos, PhD from the Children’s Hospital of Philadelphia have expertise in HLA...
Typing Buddies
We all need a little reassurance sometimes… In the past few years Next Generation Sequencing has conquered immunology labs all around the world and is actively used in both research and diagnostics. But how was it possible to develop and validate these methods? How do we verify the accuracy...
